Apollomics Inc Cl A (APLM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLM | NRBO | GDTC | ||
| Company | Apollomics Inc Cl A | Neurobo Pharmaceuticals Inc | Cytomed Therapeutics Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.2060 | 4.06 | 1.8900 | ||
| High | 0.2274 | 4.26 | 1.9900 | ||
| Low | 0.1903 | 4.06 | 1.6800 | ||
| Last | 0.2220 | 4.15 | 1.8100 | ||
| Change | +0.0167 | +0.06 | -0.1600 | ||
| % Change | +8.13% | +1.34% | -8.12% | ||
| Volume | 2,169,100 | 14,500 | 43,000 | ||
| 20-Day Average Volume | 2,340,475 | 44,110 | 200,795 | ||
| Previous Close | 0.2053 | 4.09 | 1.9700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2036 | 4.55 | 2.0577 | ||
| 20-Day Raw Stochastic | 35.58% | 12.93% | 16.67% | ||
| 20-Day Relative Strength | 46.06% | 45.52% | 40.62% | ||
| Weighted Alpha | -91.05 | -27.84 | -54.35 | ||
| Today's Opinion | 80% Sell | 24% Buy | 80% Sell | ||
| Previous Opinion | 80% Sell | 24% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Sell | 40% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.47% since 07/19/24 | -7.98% since 07/19/24 | -13.81% since 07/19/24 | ||
| Low | 0.1903 on 07/26/24 | 4.00 on 07/25/24 | 1.6800 on 07/26/24 | ||
| High | 0.2289 on 07/23/24 | 4.72 on 07/22/24 | 2.2600 on 07/23/24 | ||
| 1-Month | |||||
| %Chg | +12.06% since 06/26/24 | -14.08% since 06/26/24 | -10.86% since 06/26/24 | ||
| Low | 0.1850 on 07/01/24 | 4.00 on 07/25/24 | 1.6800 on 07/26/24 | ||
| High | 0.2890 on 07/17/24 | 5.30 on 06/27/24 | 2.4600 on 07/17/24 | ||
| 3-Month | |||||
| %Chg | -50.67% since 04/26/24 | +32.17% since 04/26/24 | -13.81% since 04/26/24 | ||
| Low | 0.1805 on 06/17/24 | 3.10 on 04/29/24 | 1.6800 on 07/26/24 | ||
| High | 0.4900 on 04/29/24 | 5.30 on 06/27/24 | 2.4800 on 05/06/24 | ||
| 6-Month | |||||
| %Chg | -72.76% since 01/26/24 | +35.18% since 01/26/24 | -51.21% since 01/26/24 | ||
| Low | 0.1805 on 06/17/24 | 2.99 on 04/24/24 | 1.6800 on 07/26/24 | ||
| High | 0.8500 on 01/30/24 | 6.75 on 03/04/24 | 3.7904 on 01/29/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,868 | 20,360 | 19,801 | ||
| Shares Outstanding, K | 89,496 | 4,906 | 10,940 | ||
| Annual Sales | 1,220,000 | 0 | 0 | ||
| Annual Net Income | -172,600,000 | -12,470,000 | -3,130,000 | ||
| Last Quarter Sales | N/A | 0 | N/A | ||
| Last Quarter Net Income | N/A | -6,710,000 | N/A | ||
| 60-Month Beta | 1.24 | -0.27 | 0.61 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.32 on 05/09/24 | N/A | ||
| Latest Earnings Date | 06/27/24 | 08/14/24 | 07/22/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||